The Claim

In adults with type 1 diabetes, insulin glargine U300 produces a more sustained insulin concentration profile over 24 hours, with lower peak levels in the first 12 hours and higher concentrations in the second 12 hours compared to insulin glargine U100, while maintaining equivalent total insulin exposure over 24 hours.

Source: Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
54score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Description
1 study reviewed
In plain English

In adults with type 1 diabetes, insulin glargine U300 provides a steadier level of insulin over 24 hours, with lower peaks in the first 12 hours and higher levels in the second 12 hours than insulin glargine U100, while delivering the same total amount of insulin over the full day.

See the scientific wording

In adults with type 1 diabetes, insulin glargine U300 produces a more sustained insulin concentration profile over 24 hours, with lower peak levels in the first 12 hours and higher concentrations in the second 12 hours compared to insulin glargine U100, while maintaining equivalent total insulin exposure over 24 hours.

Why this might work

Insulin glargine U300 forms a slow-dissolving deposit under the skin that releases insulin steadily over 24 hours, leading to lower insulin levels right after injection but higher levels later at night. This steady release keeps insulin levels high enough to block the liver from making too much sugar and the fat tissue from releasing too much fat, especially during the night. The result is less sugar and ketones in the blood over the full day.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus

    This study found that the newer insulin (Gla-300) releases insulin more slowly than the older one (Gla-100), so it gives less insulin right after injection but more insulin later at night — while still giving the same total amount over 24 hours.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.